Shots:

• MD Anderson signs an asset purchase agreement with Bellicum to acquire its 60-000-square-foot facility in Houston including its technical operation- quality staff- manufacturing- office and laboratory space for $15M. The transaction is expected to close in Q1’20
• Additionally- the companies will sign a master services agreement- under which MD Anderson will operate Bellicum’s Houston facility and manufacture its GoCAR and other cellular therapy programs for clinical trials and early commercial supply
• The supply agreement ensures Bellicum's access to cell therapy product supply while reducing its operating expenses. MD Anderson will provide employment to ~35 employees at the Houston facility

Click here ­to­ read full press release/ article | Ref: Bellicum | Image: Houston Public media